Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Effects of Intranasal Oxytocin on Approach Bias and Craving in Moderate to Heavy Alcohol Drinkers

Trial Profile

The Effects of Intranasal Oxytocin on Approach Bias and Craving in Moderate to Heavy Alcohol Drinkers

Status: Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 07 Jun 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Oxytocin (Primary)
  • Indications Alcoholism
  • Focus Therapeutic Use
  • Acronyms Oxytocin-Approach

Most Recent Events

  • 01 Jun 2022 Planned End Date changed from 20 Apr 2023 to 20 Apr 2024.
  • 01 Jun 2022 Planned primary completion date changed from 20 Apr 2022 to 20 Apr 2024.
  • 01 Jun 2022 Planned initiation date changed from 1 Nov 2021 to 1 Nov 2023.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top